Generic Vaniqa

Vaniqa Eflornithine Cream is used for slowing the growth of unwanted facial hair in women. This medicine is an enzyme inhibitor. It works by blocking an enzyme necessary for hair to grow. It should not be used in patients who are allergic to any ingredient in Eflornithine Cream. Tell your doctor or pharmacist if you have previously experienced such an allergy. It can not be used in males; girls aged less than 12 years, pregnancy and breastfeeding.

 

Vaniqa ought to be used on the face and under the chin. Avoid contact of Vaniqa Eflornithine Cream with the eyes and the moist membranes lining the inside of certain parts of the body, eg mouth, nasal passages (mucous membranes). Wash with cold water if accidental contact occurs. Keep away from using on broken or irritated skin. It should not be used on skin immediately after using any other hair removal method. It is essential to wait for at least five minutes. Wash your hands after applying the cream. For highest benefit; do not clean the treated area of skin within four hours of applying the cream. Cosmetics (including sunscreens) can be used on the treated areas, but don’t apply them sooner than five minutes after applying the cream.

If your skin becomes irritated by the cream you should try using it less regularly. If the irritation persists, stop using the cream and consult your doctor.

Excessive hair growth due to underlying diseases needs to be investigated and treated before using Vaniqa Eflornithine.

Clinical studies were made on 1373 patients on active treatment in of VANIQA, from which just about 7% were 65 years or older and approximately 1% were 75 or older. The study revealed no apparent differences in safety between older patients and younger patients.

Eflornithine Cream does not remove hair. You will need to continue your routine method of hair removal while using Vaniqa Eflornithine.

You may need to use Eflornithine Cream for at least 4 to 8 weeks before you begin to see improvement. If your symptoms do not improve or become worse, contact your doctor.

Vaniqa Eflornithine should be used with extreme caution in CHILDREN younger than 12 years of age. Safety and effectiveness in this age group have not been confirmed. Tell your doctor if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement.

In pregnancy and breast-feeding this medicine may not be right to use. If you become pregnant, check with your doctor the benefits and risks of using Eflornithine Cream during pregnancy. It is unidentified if Vaniqa Eflornithine is excreted in breast milk. If you are breast-feeding whilst you are using Eflornithine Cream, check with your doctor or pharmacist to discuss the risks to your baby.